European public payers want to see solid proof of efficacy before theyâ€™ll agree to reimburse for digital health solutions (such as apps that help patients manage chronic conditions through remote counseling). But less than 2 percent of the papers on digital therapeutics that we reviewed appeared in journals that conduct peer reviews. 